To date, vaccination has become one of the most effective strategies to control and reduce
infectious diseases, preventing millions of deaths worldwide. The earliest vaccines were …

Currently approved replication-competent and inactivated vaccines are limited by excessive
reactogenicity and poor safety profiles, while subunit vaccines are often insufficiently …

Background Quadrivalent and bivalent vaccines against oncogenic human papillomavirus
(HPV) are used worldwide with different reported overall efficacies against HPV infections …

Licensed human papillomavirus (HPV) vaccines contain virus-like particles (VLPs) self-
assembled from L1 major-capsid proteins that are remarkably effective prophylactic …

Despite rapid progress in the field, scalable high‐yield production of adeno‐associated virus
(AAV) is still one of the critical bottlenecks the manufacturing sector is facing. The insect cell …

Human papillomavirus (HPV) infection identified as a definitive human carcinogen is
increasingly being recognized for its role in carcinogenesis of human cancers. Up to 38 …

In the last 40 years, novel viruses have evolved at a much faster pace than other pathogens.
Viral diseases pose a significant threat to public health around the world. Bovines have a …

Human papillomavirus (HPV) is a significant health burden and leading cause of virus-
induced cancers. HPV is epitheliotropic and its replication is tightly associated with terminal …

Cervical cancer are generally caused by a persistent infection with the oncogenic virus,
HPV. Patients with HPV integration are more prone to develop cervical cancer than patients …

Head and neck cancer (HNC) usually arises from squamous cells of the upper aerodigestive
tract that line the mucosal surface in the head and neck region. In India, HNC is common in …